Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04680442 | Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction(SCHOLAR-2) | recruiting | Phase 2 | 130 | Population Health Research InstituteOTHER | 3 | Apr 6, 2025 | clinicaltrials |
| NCT05484973 | Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss | recruiting | N/A | 99 | Cooler Heads Care Inc.OTHER_GOV | 1 | Apr 6, 2025 | clinicaltrials |
| NCT05544240 | Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors | recruiting | Phase 1 | 20 | Williams Cancer FoundationOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06913244 | Long-Term Multidisciplinary Physiotherapy for Breast Cancer Survivors: A Randomized Controlled Trial | recruiting | N/A | 146 | Al Hayah University In CairoOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT04817566 | Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment(NeuroMod-PCCI) | recruiting | N/A | 52 | University Medicine GreifswaldOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06911528 | Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast Cancer(EDGE) | recruiting | N/A | 709 | Fudan UniversityOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06908291 | Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response Evaluation | recruiting | N/A | 500 | Peking Union Medical College HospitalOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT04025541 | Analysis of Circulating Tumor Markers in Blood(ALCINA2) | recruiting | N/A | 992 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06900647 | Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer(BOCIS) | recruiting | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06811870 | A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients | recruiting | Phase 1 / Phase 2 | 161 | Guangdong Provincial People's HospitalOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06904989 | A New Cancer Rehabilitation Process for Chemotherapy-Induced Foot Neuropathy Using Orthopedic Devices(FOTNEV) | recruiting | N/A | 40 | Vastra Gotaland RegionOTHER_GOV | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06895291 | Whole Body MRI in Oncology(ONCO-MRI) | recruiting | — | 1,000 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT05955170 | Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer(TUC-TOC) | recruiting | Phase 2 | 66 | Institut CurieOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT05416164 | DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy | recruiting | N/A | 595 | The Netherlands Cancer InstituteOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT05976815 | Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients(KEYMOVE) | recruiting | N/A | 86 | University Institute of MaiaOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06888258 | Compare Analgesia Between MTP Block And ESPB in MRM | recruiting | N/A | 90 | National Cancer Institute, EgyptOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06894173 | EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase(GIM28-ELMER) | recruiting | — | 1,000 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT03671044 | A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients | recruiting | Phase 3 | 657 | Jina Pharmaceuticals Inc.INDUSTRY | 2 | Mar 21, 2025 | clinicaltrials |
| NCT05044689 | Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria | recruiting | — | 800 | Obafemi Awolowo University Teaching HospitalOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT05867966 | Psychoneurological Symptom Cluster in Oncology | recruiting | N/A | 500 | University of LiegeOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT05332561 | Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE) | recruiting | Phase 2 | 240 | German Cancer Research CenterOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05485766 | Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer | recruiting | Phase 2 | 23 | Okayama UniversityOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06877416 | Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer | recruiting | — | 700 | Sun Yat-sen UniversityOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06880029 | Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy(CIRCADIAN) | recruiting | Phase 1 / Phase 2 | 20 | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.OTHER_GOV | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06883201 | Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer | recruiting | — | 78 | Regina Elena Cancer InstituteOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05816655 | Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer | recruiting | Phase 2 | 202 | Korea University Guro HospitalOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06050109 | The Benefits of Continued Use of Ovarian Function Suppression After 5 Years | recruiting | — | 1,200 | Hongmei Zheng, PhDOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT05465031 | Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) | recruiting | Phase 4 | 600 | Silesian Centre for Heart DiseasesOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT05968677 | Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer Patients | recruiting | N/A | 60 | Flavolife SrlINDUSTRY | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06567353 | A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases | recruiting | N/A | 10 | Ruijin HospitalOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06780735 | Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy | recruiting | N/A | 128 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06875414 | Breast Cancer and Resilience in Couple(resilience) | recruiting | — | 40 | Regina Elena Cancer InstituteOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT04510129 | A Multicenter Cancer Biospecimen Collection Study | recruiting | — | 1,650 | Cofactor Genomics, Inc.INDUSTRY | 1 | Mar 12, 2025 | clinicaltrials |
| NCT05918328 | Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC | recruiting | Phase 2 | 610 | Henan Cancer HospitalOTHER_GOV | 1 | Mar 7, 2025 | clinicaltrials |
| NCT05899387 | Seroma of the Mammary Gland(SerMa) | recruiting | N/A | 2,000 | University Hospital AugsburgOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06193525 | FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test(FUTURE) | recruiting | Phase 2 | 66 | Erasmus Medical CenterOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06851299 | The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer. | recruiting | Phase 2 | 60 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT05020860 | Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer(RESPONSE) | recruiting | Phase 2 | 185 | Baylor Breast Care CenterOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06227338 | ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study(BREASTIFLU-1) | recruiting | N/A | 250 | Jules Bordet InstituteOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT04671511 | Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer(TADEN) | recruiting | N/A | 98 | Jewish General HospitalOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT04990921 | Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer | recruiting | Phase 2 | 15 | University of LouisvilleOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT06266312 | Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With Breastcancer(APRIORI) | recruiting | N/A | 11 | Maastricht University Medical CenterOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT06835426 | High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins | recruiting | N/A | 150 | Algemeen Ziekenhuis Maria MiddelaresOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06259929 | NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer(Neo-AGILE) | recruiting | Phase 2 | 51 | Fondazione OncotechOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06832904 | Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05) | recruiting | Phase 2 | 33 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06272864 | BostonGene and Exigent Genomic INsight Study(BEGIN) | recruiting | — | 400 | BostonGeneINDUSTRY | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06318507 | The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy(IMPACT) | recruiting | — | 25 | Pennington Biomedical Research CenterOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06642545 | Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ± Toripalimab in HR-/HER2-low Breast Cancer | recruiting | Phase 2 | 40 | RemeGen Co., Ltd.INDUSTRY | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06830083 | Hypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction(HFIBR) | recruiting | N/A | 840 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06826885 | Safety and Efficacy of IMPT or IMRT for Breast Cancer(SEPPT-BC) | recruiting | — | 500 | Ruijin HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Apr 6, 2025source: clinicaltrials